Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | ABC1 family protein | 0.0035 | 0.0814 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.007 | 0.2537 | 0.3654 |
Loa Loa (eye worm) | hypothetical protein | 0.0161 | 0.6943 | 1 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0018 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0136 | 0.5738 | 0.8264 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0035 | 0.0814 | 1 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0018 | 0 | 0.5 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0018 | 0 | 0.5 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0035 | 0.0814 | 0.1173 |
Brugia malayi | RNA binding protein | 0.007 | 0.2537 | 0.3654 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0035 | 0.0814 | 1 |
Mycobacterium ulcerans | lipase LipD | 0.0035 | 0.0814 | 1 |
Brugia malayi | hypothetical protein | 0.0136 | 0.5738 | 0.8264 |
Plasmodium vivax | hypothetical protein, conserved | 0.0035 | 0.0814 | 1 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0035 | 0.0814 | 0.3209 |
Brugia malayi | beta-lactamase family protein | 0.0035 | 0.0814 | 0.1173 |
Mycobacterium leprae | conserved hypothetical protein | 0.0035 | 0.0814 | 0.5 |
Mycobacterium tuberculosis | Probable lipase LipE | 0.0035 | 0.0814 | 0.0814 |
Onchocerca volvulus | Huntingtin homolog | 0.0136 | 0.5738 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0035 | 0.0814 | 1 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0018 | 0 | 0.5 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0035 | 0.0814 | 0.3209 |
Brugia malayi | beta-lactamase family protein | 0.0035 | 0.0814 | 0.1173 |
Loa Loa (eye worm) | RNA binding protein | 0.007 | 0.2537 | 0.3654 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0814 | 0.1173 |
Brugia malayi | beta-lactamase | 0.0035 | 0.0814 | 0.1173 |
Brugia malayi | Muscleblind-like protein | 0.0161 | 0.6943 | 1 |
Mycobacterium tuberculosis | Probable esterase LipL | 0.0035 | 0.0814 | 0.0814 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0035 | 0.0814 | 0.1173 |
Brugia malayi | RNA recognition motif domain containing protein | 0.007 | 0.2537 | 0.3654 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.2537 | 1 |
Mycobacterium tuberculosis | Conserved protein | 0.0035 | 0.0814 | 0.0814 |
Mycobacterium tuberculosis | Probable conserved lipoprotein | 0.0035 | 0.0814 | 0.0814 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0035 | 0.0814 | 0.1173 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0035 | 0.0814 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0035 | 0.0814 | 1 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0035 | 0.0814 | 0.1173 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0035 | 0.0814 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0814 | 0.1173 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.2537 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0161 | 0.6943 | 1 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0161 | 0.6943 | 1 |
Echinococcus granulosus | muscleblind protein | 0.0161 | 0.6943 | 1 |
Mycobacterium tuberculosis | Possible conserved lipoprotein LpqK | 0.0035 | 0.0814 | 0.0814 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.2537 | 1 |
Onchocerca volvulus | Huntingtin homolog | 0.0136 | 0.5738 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0814 | 0.1173 |
Trichomonas vaginalis | esterase, putative | 0.0035 | 0.0814 | 1 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0035 | 0.0814 | 1 |
Mycobacterium leprae | Probable lipase LipE | 0.0035 | 0.0814 | 0.5 |
Mycobacterium ulcerans | beta-lactamase | 0.0035 | 0.0814 | 1 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0035 | 0.0814 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.007 | 0.2537 | 0.3654 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.007 | 0.2537 | 0.3654 |
Mycobacterium tuberculosis | Probable esterase/lipase LipP | 0.0035 | 0.0814 | 0.0814 |
Mycobacterium tuberculosis | Conserved protein | 0.0035 | 0.0814 | 0.0814 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.2537 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0035 | 0.0814 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.2537 | 1 |
Mycobacterium tuberculosis | Probable hydrolase | 0.0035 | 0.0814 | 0.0814 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0814 | 0.1173 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0814 | 0.1173 |
Mycobacterium tuberculosis | Probable lipase LipD | 0.0035 | 0.0814 | 0.0814 |
Echinococcus multilocularis | muscleblind protein | 0.0161 | 0.6943 | 1 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0035 | 0.0814 | 1 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0018 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0814 | 0.1173 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0035 | 0.0814 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.007 | 0.2537 | 0.3654 |
Mycobacterium ulcerans | hypothetical protein | 0.0035 | 0.0814 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0136 | 0.5738 | 0.8264 |
Mycobacterium tuberculosis | Conserved protein | 0.0035 | 0.0814 | 0.0814 |
Brugia malayi | TAR-binding protein | 0.007 | 0.2537 | 0.3654 |
Loa Loa (eye worm) | beta-lactamase | 0.0035 | 0.0814 | 0.1173 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.